Drug therapy for Helicobacter pylori infection: problems and pitfalls.
about
Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pyloriResponse to metronidazole and oxidative stress is mediated through homeostatic regulator HsrA (HP1043) in Helicobacter pylori.Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacyEfficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.Helicobacter pylori and peptic ulcer disease.High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children.Helicobacter pylori and peptic ulcers: the present position.One week's anti-Helicobacter pylori treatment for duodenal ulcer.Mucosal peptic activity during Helicobacter pylori infection in pediatric patients.High Helicobacter pylori numbers are associated with low eradication rate after triple therapyAssociation of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.Indications for treatment of Helicobacter pylori infection: a systematic overview.Antibiotic resistance of Helicobacter pylori strains in Japanese childrenUtilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori.Diagnostic methods for Helicobacter pylori detection and eradicationAnimal and public health implications of gastric colonization of cats by Helicobacter-like organisms.Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori.In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA(+) (Nitroreductase) gene.In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori.Eradicating Helicobacter pylori in patients with duodenal ulcer.The coccoid forms of Helicobacter pylori. Criteria for their viability.Coptisine-induced inhibition of Helicobacter pylori: elucidation of specific mechanisms by probing urease active site and its maturation process
P2860
Q25257357-08B5DBA6-54B3-4793-8EEE-61DD95B755C8Q30411563-C6B4611A-36E7-4288-BCF2-CAFCEF2C74FBQ33338688-CAB49D39-03E3-4499-9525-9263E60307A4Q33452908-073C48C8-A156-40A3-8E07-DAF7C4FFD9EFQ33607500-1E224D4C-7347-472A-A538-1C163821DF0EQ33971057-C08A6707-C783-4CD4-9D60-E54CB67EC113Q34375061-FD00AC9D-66A1-4E00-910D-9B05E2E34570Q34378373-FF1640AA-13F4-4563-BFC3-33EAD3AE8DA9Q34396049-A54E9A63-D185-49E3-9A93-DAEE5EAAA015Q34408111-A3CC040F-9DE6-498C-A8B8-28AFC5D46981Q34636521-6FF9C38E-A263-4BCD-A0CB-001EC300700BQ34707933-1F02B0CF-7AAB-44F6-897A-1811BB6723CEQ34946883-B37AEB6E-2805-46B5-A972-B7972240D229Q35110775-D5D799AD-05B8-4C47-B51D-0A899D8B2424Q35120681-D7619DDD-F8BE-4D3E-921D-E1F5E743A2D5Q35200053-1E06F3A4-95F8-43FB-BC2D-B7348915FB64Q37165592-17481C96-9E85-4AEE-9DB1-F59FA1EC6834Q37242990-FF18690B-98CF-403F-B5BD-FBD03B099CEEQ39478171-FAD52020-7C13-486A-B2EA-68B9CDCA8279Q39500646-193AC217-1BB8-4BFB-9232-487502D3B2B4Q40285071-E38E5975-44C1-42D8-AAEE-37A41AC800B8Q42761505-079FB17B-FE2B-46AE-9AF4-EF3957A1330CQ43082126-C1100F68-79B7-4846-ACC8-F73B48D67CD0Q58759028-D0363812-A96D-490E-915F-03A0CC2A2153
P2860
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
@en
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
@nl
type
label
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
@en
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
@nl
prefLabel
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
@en
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
@nl
P1476
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
@en
P2093
Glupczynski Y
P304
P407
P577
1990-12-01T00:00:00Z